Aflac [AFL] vs MetLife [MET] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Aflac Inc. wins in 11 metrics, MetLife Inc. wins in 9 metrics, with 0 ties. Aflac Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Aflac Inc. | MetLife Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.88 | 16.15 | MetLife Inc. |
| Price-to-Book Ratio | 2.02 | 1.76 | MetLife Inc. |
| Debt-to-Equity Ratio | 42.68 | 225.97 | Aflac Inc. |
| PEG Ratio | -0.74 | -0.48 | MetLife Inc. |
| EV/EBITDA | 13.45 | 15.07 | Aflac Inc. |
| Profit Margin (TTM) | 21.24% | 4.38% | Aflac Inc. |
| Operating Margin (TTM) | 33.56% | 4.67% | Aflac Inc. |
| EBITDA Margin (TTM) | 33.56% | 4.67% | Aflac Inc. |
| Return on Equity | 13.12% | 12.02% | Aflac Inc. |
| Return on Assets (TTM) | 2.54% | 0.46% | Aflac Inc. |
| Free Cash Flow (TTM) | $2.56B | $17.09B | MetLife Inc. |
| Dividend Yield | 2.58% | 3.03% | MetLife Inc. |
| 1-Year Return | 15.29% | 14.85% | Aflac Inc. |
| Price-to-Sales Ratio (TTM) | 3.46 | 0.64 | MetLife Inc. |
| Enterprise Value | $64.40B | $89.84B | MetLife Inc. |
| EV/Revenue Ratio | 3.75 | 1.17 | MetLife Inc. |
| Revenue per Share (TTM) | $32 | $115 | MetLife Inc. |
| Earnings per Share (Diluted) | $6.82 | $4.71 | Aflac Inc. |
| Beta (Stock Volatility) | 0.65 | 0.73 | Aflac Inc. |
| Short % of Float | 2.08% | 2.61% | Aflac Inc. |
Aflac Inc. vs MetLife Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Aflac Inc. | -0.71% | 1.49% | 0.13% | 7.19% | 4.90% | 6.10% |
| MetLife Inc. | -1.33% | 3.89% | 9.88% | 26.75% | 6.11% | 9.14% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Aflac Inc. | 15.29% | 69.67% | 126.19% | 242.44% | 423.32% | 407.10% |
| MetLife Inc. | 14.85% | 60.07% | 52.38% | 136.40% | 146.91% | 99.01% |
Performance & Financial Health Analysis: Aflac Inc. vs MetLife Inc.
| Metric | AFL | MET |
|---|---|---|
| Market Information | ||
| Market Cap | $59.05B | $49.60B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 2,109,423 | 3,185,584 |
| 90 Day Avg. Volume | 2,335,318 | 3,535,355 |
| Last Close | $116.96 | $87.66 |
| 52 Week Range | $96.95 - $119.81 | $67.33 - $89.62 |
| % from 52W High | -2.38% | -2.19% |
| All-Time High | $119.81 (May 19, 2026) | $89.62 (Jun 15, 2026) |
| % from All-Time High | -2.38% | -2.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.10% | 0.28% |
| Quarterly Earnings Growth | -0.28% | -0.36% |
| Financial Health | ||
| Profit Margin (TTM) | 0.21% | 0.04% |
| Operating Margin (TTM) | 0.34% | 0.05% |
| Return on Equity (TTM) | 0.13% | 0.12% |
| Debt to Equity (MRQ) | 42.68 | 225.97 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $56.86 | $43.33 |
| Cash per Share (MRQ) | $14.78 | $39.31 |
| Operating Cash Flow (TTM) | $2.56B | $17.09B |
| Levered Free Cash Flow (TTM) | $5.18B | $-12,738,499,584 |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.58% | 3.03% |
| Last 12-Month Dividend | $2.93 | $2.28 |
Valuation & Enterprise Metrics Analysis: Aflac Inc. vs MetLife Inc.
| Metric | AFL (Apr 26, 2026) | MET (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.88 | 16.15 |
| Forward P/E | 14.93 | 6.95 |
| PEG Ratio | -0.74 | -0.48 |
| Price to Sales (TTM) | 3.46 | 0.64 |
| Price to Book (MRQ) | 2.02 | 1.76 |
| Market Capitalization | ||
| Market Capitalization | $59.05B | $49.60B |
| Enterprise Value | $64.40B | $89.84B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.75 | 1.17 |
| Enterprise to EBITDA | 13.45 | 15.07 |
| Risk & Other Metrics | ||
| Beta | 0.65 | 0.73 |
| Book Value per Share (MRQ) | $56.86 | $43.33 |
Financial Statements Comparison: Aflac Inc. vs MetLife Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | AFL (2025) | MET (2025) |
|---|---|---|
| Revenue/Sales | 17.36B | 75.65B |
| Cost of Goods Sold | N/A | N/A |
| COGS % of Revenue | 0.0% | 0.0% |
| Gross Profit | N/A | N/A |
| Gross Margin | 0.0% | 0.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| Operating Margin | 0.0% | 0.0% |
| EBITDA | N/A | N/A |
| EBITDA Margin | 0.0% | 0.0% |
| Pre-Tax Income | 4.53B | 4.66B |
| Pre-Tax Income % of Revenue | 26.1% | 6.2% |
| Income Tax | 887.00M | 1.26B |
| Income Tax % of Revenue | 5.1% | 1.7% |
| Net Income (Profit) | 3.65B | 3.40B |
| Profit Margin | 21.0% | 4.5% |
Balance Sheet & Liquidity Metrics
| Metric | AFL (2025) | MET (2025) |
|---|---|---|
| Cash & Equivalents | 6.25B | 22.03B |
| Total Current Assets | N/A | N/A |
| Total Current Assets % of Revenue | 0.0% | 0.0% |
| Total Current Liabilities | N/A | N/A |
| Total Current Liabilities % of Revenue | 0.0% | 0.0% |
| Long-Term Debt | 8.41B | 18.62B |
| Long-Term Debt % of Revenue | 48.5% | 24.6% |
| Total Shareholders Equity | 29.49B | 28.92B |
| Retained Earnings | 54.68B | 44.29B |
| Retained Earnings % of Revenue | 315.1% | 58.5% |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison
| Metric | AFL (2025) | MET (2025) |
|---|---|---|
| Operating Cash Flow | 3.50B | -873.00M |
| Operating Cash Flow % of Revenue | 20.2% | -1.2% |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | 2.56B | 17.09B |
| FCF Margin | 14.7% | 22.6% |
| Debt Repayment | -84.00M | -2.62B |
| Common Stock Repurchase | -3.53B | -3.88B |
Short Interest & Institutional Ownership Analysis
| Metric | AFL | MET |
|---|---|---|
| Shares Short | 8.35M | 14.12M |
| Short Ratio | 3.23 | 3.48 |
| Short % of Float | 2.08% | 2.61% |
| Shares Outstanding | 518.69M | 655.33M |
| Float Shares | 512.03M | 544.55M |
| % Held by Insiders | 10.85% | 16.44% |
| % Held by Institutions | 59.81% | 76.90% |
| % Held by Public | 29.34% | 6.66% |
Dividend Analysis & Yield Comparison: Aflac Inc. vs MetLife Inc.
| Metric | AFL | MET |
|---|---|---|
| Last 12-Month Dividend | $2.93 | $2.28 |
| Last 12-Month Dividend Yield | 2.58% | 3.03% |
| 3-Year Avg Annual Dividend | $2.06 | $2.19 |
| 3-Year Avg Dividend Yield | 0.55% | 0.78% |
| 3-Year Total Dividends | $6.19 | $6.56 |
| Ex-Dividend Date | Feb 18, 2026 | Feb 03, 2026 |